- Home
- BPTH vs VRPX Comparison
BPTH vs VRPX Comparison
Compare BPTH & VRPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- VRPX
- Stock Information
- Founded
- BPTH 2007
- VRPX 2016
- Country
- BPTH United States
- VRPX United States
- Employees
- BPTH N/A
- VRPX N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- VRPX Medicinal Chemicals and Botanical Products
- Sector
- BPTH Health Care
- VRPX Health Care
- Exchange
- BPTH Nasdaq
- VRPX Nasdaq
- Market Cap
- BPTH 4.0M
- VRPX 3.7M
- IPO Year
- BPTH N/A
- VRPX 2021
- Fundamental
- Price
- BPTH $0.82
- VRPX $0.57
- Analyst Decision
- BPTH Strong Buy
- VRPX Hold
- Analyst Count
- BPTH 2
- VRPX 1
- Target Price
- BPTH $30.00
- VRPX N/A
- AVG Volume (30 Days)
- BPTH 107.7K
- VRPX 8.4M
- Earning Date
- BPTH 11-15-2024
- VRPX 11-14-2024
- Dividend Yield
- BPTH N/A
- VRPX N/A
- EPS Growth
- BPTH N/A
- VRPX N/A
- EPS
- BPTH N/A
- VRPX N/A
- Revenue
- BPTH N/A
- VRPX N/A
- Revenue This Year
- BPTH N/A
- VRPX N/A
- Revenue Next Year
- BPTH N/A
- VRPX N/A
- P/E Ratio
- BPTH N/A
- VRPX N/A
- Revenue Growth
- BPTH N/A
- VRPX N/A
- 52 Week Low
- BPTH $0.61
- VRPX $0.36
- 52 Week High
- BPTH $12.40
- VRPX $5.51
- Technical
- Relative Strength Index (RSI)
- BPTH 40.36
- VRPX 40.40
- Support Level
- BPTH $0.74
- VRPX $0.55
- Resistance Level
- BPTH $0.85
- VRPX $0.72
- Average True Range (ATR)
- BPTH 0.09
- VRPX 0.11
- MACD
- BPTH -0.01
- VRPX -0.01
- Stochastic Oscillator
- BPTH 53.85
- VRPX 6.30
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About VRPX Virpax Pharmaceuticals Inc.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.